RGD-conjugated gold nanorods induce radiosensitization in melanoma cancer cells by downregulating αvβ3 expression by Xu, Wencai et al.
© 2012 Xu et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article  
which permits unrestricted noncommercial use, provided the original work is properly cited.
International Journal of Nanomedicine 2012:7 915–924
International Journal of Nanomedicine
RGD-conjugated gold nanorods induce 
radiosensitization in melanoma cancer cells  
by downregulating αvβ3 expression
Wencai Xu1
Teng Luo2
Ping Li1
Chuanqing Zhou2
Daxiang Cui3
Bo Pang4
Qiushi Ren4
Shen Fu1
1Department of Radiation Oncology, 
Shanghai Sixth People’s Hospital, 
2School of Biomedical Engineering, 
and 3National Key Laboratory of 
Nano/Micro Fabrication Technology, 
Key Laboratory for Thin Film and 
Microfabrication of Ministry of 
Education, Institute of Micro-Nano 
Science and Technology, Shanghai 
Jiao Tong University, Shanghai, 
4Department of Biomedical 
Engineering, College of Engineering, 
Peking University, Beijing, People’s 
Republic of China
Correspondence: Shen Fu 
Department of Radiation Oncology,  
Sixth People’s Hospital of Jiao Tong  
University, 600 Yi Shan Road,  
Shanghai 200233,  
People’s Republic of China 
Tel +86 021 6436 9181 
Fax +86 021 2405 8643 
Email fushen1117@163.com 
 
Qiushi Ren  
Department of Biomedical Engineering, 
College of Engineering, Peking University, 
600 Yi Shan Road, Beijing 100871, 
People’s Republic of China 
Tel +86 010 6436 9181 
Fax +86 010 2405 8643 
Email renqsh@coe.pku.edn.cn
Background: Melanoma is known to be radioresistant and traditional treatments have been 
intractable. Therefore, novel approaches are required to improve the therapeutic efficacy of 
melanoma treatment. In our study, gold nanorods conjugated with Arg-Gly-Asp peptides 
(RGD-GNRs) were used as a sensitizer to enhance the response of melanoma cells to 6 mV 
radiation.
Methods and materials: A375 melanoma cells were treated by gold nanorods or RGD-GNRs 
with or without irradiation. The antiproliferative impact of the treatments was measured by MTT 
assay. Radiosensitizing effects were determined by colony formation assay. Apoptosis and cell 
cycle data were measured by flow cytometry. Integrin αvβ3 expression was also investigated 
by flow cytometry.
Results: Addition of RGD-GNRs enhanced the radiosensitivity of A375 cells with a dose-
modifying factor of 1.35, and enhanced radiation-induced apoptosis. DNA flow cytometric 
analysis indicated that RGD-GNRs plus irradiation induced significant G2/M phase arrest in 
A375 cells. Both spontaneous and radiation-induced expressions of integrin αvβ3 were down-
regulated by RGD-GNRs.
Conclusion: Our study indicated that RGD-GNRs could sensitize melanoma A375 cells to 
irradiation. It was hypothesized that this was mainly through downregulation of radiation-
induced αvβ3, in addition to induction of a higher proportion of cells within the G2/M phase. 
The combination of RGD-GNRs and radiation needs further investigation.
Keywords: radiosensitivity, melanoma, Arg-Gly-Asp peptides, gold nanorods, integrin αvβ3, 
G2/M arrest
Introduction
Radiation therapy is one of the commonly utilized treatments for cancer. However, local 
failure after irradiation remains a challenge due to intrinsic and acquired resistance of 
tumor cells to radiation treatment. Radiation not only eradicates tumor cells through 
DNA damage and apoptosis, but also influences cell adhesion to the extracellular 
matrix by regulating receptors such as integrins.1
Integrins are composed of a single alpha and a single beta chain that have 
  activated or nonactivated conformations. There are eight known beta subunits and 18 
alpha subunits that can be combined to form over 24 known mammalian integrins.2 
A substantial body of data support the view that integrins, such as αvβ3, play a criti-
cal role in regulating tumor growth and metastasis as well as tumor angiogenesis.3,4 
αvβ3 is expressed on the surface of a variety of cells, including endothelial cells and 
certain tumor cells in human malignant melanoma, breast cancer, and advanced 
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  glioblastoma.4 Integrin αvβ3 expression not only affects tumor 
radiosensitivity,5 but is also associated with acquired radiore-
sistance through the upregulation of integrin expression by 
radiation.6,7 Therefore, targeting integrin αvβ3 has received 
relatively more attention due to its role as a potential target 
for inhibition of angiogenesis and tumor growth.3 Arginine 
(R)-glycine (G)-aspartate (D) (RGD) is the most effective and 
widely used peptide sequence for stimulating cell adhesion 
on synthetic material surfaces. The RGD sequence is present 
in many extracellular matrix proteins and can interact with 
integrin receptors at focal adhesion points. Once the RGD 
sequence is recognized and bound to integrins, it initiates an 
integrin-mediated cell adhesion process and activates signal 
transduction between the cell and extracellular matrix, thus 
influencing cell behavior on the substrate (eg, proliferation, 
differentiation, apoptosis, survival, and migration).8 Cyclic 
RGD-containing pentapeptides, such as cilengitide, are the 
most commonly used integrin αvβ3 inhibitors and enhance 
the response of different cancer cells to irradiation.9,10
Although it is anticipated that RGD peptides will be 
very promising as radiosensitizers, success in enhancing 
the radiotherapeutic ratio for cancer depends on increasing 
tumor cytotoxicity while simultaneously reducing harmful 
effects on normal tissues. An ideal strategy would be to 
identify a radiosensitizer that preferentially and effectively 
enhances the process of radiation-induced cell death in 
tumor cells which can be coupled with a delivery system 
that will increase inhibition of tumor tissues in a targeted 
way without affecting normal tissue. Recently, there have 
been efforts to develop a nanomedicine that actively targets 
cancer cells and contains effective anticancer drugs to exploit 
cancer-specific molecular targets.11 Nanotechnology is an 
emerging technique for improved cellular targeting and 
radiosensitization. Gold nanorods are widely used as delivery 
vehicles to carry chemotherapeutic agents or radiosensitizers 
to malignant cells in the treatment of cancer.12 Gold nanorods 
have low cytotoxicity, robust stability, biocompatibility, and 
suitable physiochemical parameters, and some studies have 
reported that gold nanorods functionalized with drug mol-
ecules show substantially expanded performance as efficient 
therapeutic drug carriers. The use of structurally modified 
gold nanorods is less toxic to normal tissue during delivery, 
and at the molecular level, could traverse biologic barriers 
and preferentially accumulate in cancer cells.13,14 Achieving 
the development of a competent cancer nanomedicine may 
bring new hope to cancer patients.
The present study investigated the benefit of combining 
RGD-conjugated gold nanorods (RDG-GNRs) that target 
integrin αvβ3 with irradiation in melanoma cancer cells, and 
also considered some possible mechanisms for the radiosen-
sitizing effects of RGD-GNRs.
Materials and methods
Preparation of RGD-GNRs
The gold nanorods were synthesized using the seed-mediated 
template-assisted protocol,15,16 by reducing gold salt in the 
presence of surfactant-directed synthesis. First, a 20 mL 
aliquot of gold nanorod stock solution (Sinopharm Chemical 
Reagent Co, Shanghai, China) was centrifuged and redis-
persed in 20 mL deionized water (Millipore, Shanghai, 
China). Then, 1.1 mL of 10 mM tetraethyl orthosilicate 
ethanol solution (J & K Chemical Ltd, Shanghai, China) was 
added to the 20 mL of aqueous gold nanorods (pH adjusted 
to 10–11 by NH4OH). After vigorous stirring for 10 hours 
at room temperature, an approximately 31 nm thick silica 
layer formed on the surface of the gold nanorods through 
hydrolysis and condensation of tetraethyl orthosilicate.17 The 
silica-coated nanoparticles were isolated by centrifugation, 
washed with deionized water and ethanol several times, and 
then dispersed in deionized water for later use. To create 
molecularly targeted particles, the gold nanorod surfaces 
were modified by cycle RGD peptides (Shanghai, China) 
using the standard EDC-NHS reaction as described by Johns-
son et al.18 A solution of RGD in deionized water was added to 
a volume of silica-coated gold nanorods to react for 48 hours 
and excess RGD peptides were removed by centrifugation at 
6000 rpm for 15 minutes. The RGD-GNRs were dispersed 
in Dulbecco’s Modified Eagle Medium (Hyclone, Carlsbad, 
CA) and stored at 4°C for later cell experiments.
Cell lines and culture
Human melanoma A375 cells were purchased from the 
  Shanghai Institute of Cell Biology and Chinese Academy of 
Sciences (Shanghai, China) and grown in flasks containing 
Dulbecco’s Modified Eagle Medium with 10%   heat-inactivated 
fetal bovine serum (Hyclone). Cells were incubated at 37°C in 
a humidified atmosphere with 50 mL/L CO2.
Transmission electron microscopic 
analysis of cells with internalized gold 
nanorods
A375 cells previously incubated with RGD-GNRs were 
washed three times with phosphate-buffered saline and 
fixed with 2.5% glutaraldehyde for six hours. The cells were 
postfixed in 1% osmium tetroxide for 2 hours, dehydrated 
in ethanol, and embedded in agar resin (Agar Scientific, 
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  Stansted, Essex, UK). Thin sections (60–70 nm) were 
  collected on copper grids, stained with methanol and lead 
citrate, and visualized using transmission electron micros-
copy (Philips CM120).
Cellular proliferation assay
Exponentially growing cells were incubated in six-well cul-
ture dishes in the presence of RGD-GNRs or gold nanorods 
alone at different concentrations for a series of times. Then, 
15 µL of MTT solution (5 mg/mL; Sigma-Aldrich, Shanghai, 
China) was added to each well and the cells were incubated 
for 4 hours. The reaction was stopped by removal of MTT, 
and 100 µL of dimethylsulfoxide (Sigma-Aldrich) was added 
to each well to dissolve the formazan crystals, then plates 
were read at 570 nm. All experiments were repeated three 
times and measurements were done in triplicate.
Irradiation
Cells in a monolayer were irradiated using 6 mV x-rays from 
linear accelerators (Siemens, Münich, Germany) at a dose 
rate of 3 Gy/minute at room temperature. A 1.5 cm bolus 
was used as a compensator.
Clonogenic assay
A total of about 5 × 105 cells were first seeded and grown in 
six-well culture plates for 24 hours, and then incubated with 
RGD-GNRs or gold nanorods alone (50 µg/mL) for one hour 
prior to irradiation. Next, the cells were detached, seeded, 
and grown in six-well culture plates for 2 weeks to form 
colonies. The colonies were stained with 0.4% crystal violet 
and the count of colonies containing .50 cells was used for 
the calculation of the surviving fraction (SF). Values were 
expressed as the mean ± standard deviation. All experiments 
were repeated three times. Survival curves were fitted to a LQ 
model using Graphpad Prism software (version 5.0). Survival 
fraction at 2Gy (SF2) and dose-modifying factor values were 
used to quantify the radiosensitizing effect of the cells.
Cell cycle and apoptosis assays by flow 
cytometry
A375 cells (106 cells/mL) fixed in 95% ethanol at −20°C for 
24 hours were washed with cold phosphate-buffered saline, 
resuspended, and stained with propidium iodide (50 µg/mL 
phosphate-buffered saline; Invitrogen, Shanghai, China) 
for 15 minutes at 4°C. Analysis was performed using a 
FACSCalibur flow cytometer (Becton-Dickinson, Frank-
lin Lakes, NJ). Cellular DNA content and cell cycle data 
were analyzed by flow cytometry using multicycle system 
2.0 software. For the apoptosis assay, the cells were stained 
with Annexin-  V-fluorescein isothiocyanate/propidium iodide 
(Invitrogen) and measured by flow cytometry. All tests were 
repeated three times.
Integrin αvβ3 analysis
A375 cells were collected and suspended in phosphate-
buffered saline/0.2% bovine serum albumin at a concentra-
tion of 106 cells/mL. A 200 µL sample of the suspension 
was incubated with a mouse antihuman integrin αvβ3 mAb 
LM609 (Millipore, Shanghai, China) or isotype-matched 
control antibody DD7 (Millipore) for 45 minutes at 4°C. The 
cells were washed three times with phosphate-buffered saline 
and analyzed using a FACSCalibur flow cytometer. Specific 
fluorescence index values were calculated by dividing mean 
fluorescence obtained with specific Ab by mean fluorescence 
obtained with isotype control Ab.19
Statistical analysis
SPSS statistical software (v13.0, SPSS Inc, Chicago, IL) was 
used for the statistical analyses. The results were expressed 
as the mean ± standard deviation. One-way analysis of vari-
ance was performed to compare the means between two test 
groups, with a P value #0.05 considered to be statistically 
significant.
Results
Cellular toxicity and uptake of RGD-
GNRs by A375 cells
Gold nanoparticles were stabilized and grown to linear gold nan-
orods with the assistance of a reversible   adsorption-desorption 
process of high concentrations of cetyltrimethylammonium 
bromide (CTAB) surfactant in a reaction medium. However, 
CTAB-coated gold nanorods (length 44.44 ± 4.7 nm; width 
15.10 ± 1.7 nm) do not open any available sites for surface 
modification and CTAB showed high cell toxicity. For silica 
coating (thickness about 31 nm, Figure 1A and B), surface-
occupying CTAB was washed away via multiple centrifuge-
precipitation processes.20 The structures of the gold nanorods 
and the cellular uptake of RGD-GNRs were visualized using 
transmission electron microscopy. After the A375 cells were 
incubated with RGD-GNRs for one hour, RGD-GNRs could 
be located both on the surface of the cell membranes and inter-
nalized into A375 cells via integrin   αvβ3-receptor-mediated 
endocytosis21,22 (Figure 1C and D). MTT assays showed that 
both the gold nanorods and RGD-GNRs had antiproliferative 
effects in a dose-dependent manner and that   RGD-GNRs 
were significantly (P , 0.05) more toxic to the cells than the 
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gold nanorods (Figure 2A). To evaluate the ability of gold 
nanorods and RGD-GNRs to sensitize the cells to radiation, 
50 µg/mL of gold nanorods and RGD-GNRs that were slightly 
toxic after 24 hours in culture (Figure 2B) were used for the 
radiosensitization experiments.
Radiosensitization of melanoma cells  
by RGD-GNRs
A colony formation assay was used to compare the radiosen-
sitizing effect of gold nanorods and RGD-GNRs in melanoma 
cells. The dose-response curves of the cells are shown in 
  Figure 3. After irradiation treatment in combination with 
either gold nanorods or RGD-GNRs, the radiosensitizing 
effect was quantified by a dose-modifying factor based on 
the survival fraction at 2 Gy. Both gold nanorods alone and 
  RGD-GNRs enhanced the radiosensitivity of A375 cells to 
6 mV x-rays with a dose-modifying factor (SF2) of 1.14 
and 1.35,   respectively. These differences were statistically 
  significant compared with radiation alone (P , 0.05).   One-way 
analysis of variance shows that more   radiosensitization was 
observed for cells containing RGD-GNRs compared with 
cells   containing gold nanorods alone (P = 0.001).
Enhanced radiation-induced apoptosis  
by RGD-GNRs in melanoma cells
The percentages of A375 cells in apoptosis after the various 
treatments are shown in Figure 4. Cellular incorporation of gold 
nanorods alone or RGD-GNRs did not significantly increase the 
amount of cell apoptosis compared with controls. Radiation alone 
or combined with gold nanorods slightly enhanced apoptosis 
(4.97% ± 0.83% and 7.67% ±0.31%, respectively); there was a 
statistically significant difference between treated and untreated 
cells (2.23% ± 0.42%, P , 0.05). However, cells treated with 
RGD-GNRs plus radiation underwent significantly (P , 0.05) 
more apoptosis (15.10% ± 0.96%) compared with other cells.
Enhancement of radiation-induced G2 
cell cycle arrest by RGD-GNRs
Because the radiosensitivity of tumor cells is cell cycle-
oriented, more radiosensitivity was observed in the G2/M 
A
C
B
D
100 nm
Nucleus
RGD-GNRs
Cytoplasm
Cytoplasm
SiO2
GNR
500 nm 2 µm
20 nm
Figure 1 Gold nanorods and internalization by human melanoma A375 cells. (A and B) Nanoparticles shown at different magnifications as viewed by transmission electron 
microscopy. The gold nanorods were coated with an approximately 31 nm silica layer. (C and D) A375 melanoma cell shows evidence of internalized RGD-GNRs. Gold 
nanorods were internalized into cells by endocytosis at the cell membrane, and mainly distributed in cytoplasm. 
Abbreviations: GNR, gold nanorod; RGD-GNRs, arginine-glycine-aspartate-conjugated gold nanorods.
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phase and less in the G0/G1 or S phase. In Figure 5, 
  treatment of A375 cells with GNRs, RGD-GNRs, or radia-
tion alone (6 mV x-rays with a dose of 4 Gy) significantly 
induced cell cycle arrest at the G2/M phase (35% ± 2.65%, 
36.14% ± 0.35%, and 40.9% ± 0.35%, respectively). There 
were significant   differences compared with the control cells 
(25.84% ± 0.49%; P , 0.05), but not among the single 
treatment groups. The cells treated with a combination of 
RGD-GNRs plus   radiation further enhanced arrest of the 
cells at the G2/M phase (46.5% ± 1.2%). One-way   analysis 
of   variance has also shown that there were significant 
  differences between the   RGD-GNRs plus radiation group and 
both untreated and single treatment groups (P , 0.05).
Integrin αvβ3 expression levels and effect 
of irradiation and RGD-GNRs
Radiation induced a significant expression of integrin αvβ3 
in a dose-dependent manner (Figure 6). Incubating the cells 
with GNRs did not impact the expression of integrin αvβ3, 
but RGD-GNRs could effectively reduce the spontaneous 
expression of integrin αvβ3 compared with the results of the 
untreated cells (P , 0.05). While the cells incubated with 
RGD-GNRs one hour prior to radiation at 4 Gy, RGD-GNRs 
could inhibit both spontaneous and radiation-induced αvβ3 
expression, while untreated or radiation alone could not 
(P = 0.001).
Discussion
The incidence of melanoma is on the rise worldwide, with 
an estimated age-standardized incidence rate of 40.2 cases 
per 100,000 population in 2008.23 Melanoma cells are well 
known to be resistant to radiation, so any new strategies that 
overcome the relative radioresistance of melanoma tumors 
could prove to be useful and beneficial to many patients. 
In the present study, we used gold nanorods as a delivery 
system and conjugated these to cyclic RGD peptides, an 
antagonist of integrin αvβ3, to target tumor cells. Since CTAB 
is a necessary structure-directing agent in the gold nanorod 
synthesis method, severe cytotoxicity and low stability are 
still two problems which CTAB-coated gold nanorods need 
to solve. One of the solutions to these problems is depositing 
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an   additional coating on the surface of CTAB-coated gold 
nanorods. Because silica has been reported to be stable and 
have low toxicity, it is very suitable for use as a coating mate-
rial for gold nanorods.24,25 Another feature of a silica system is 
that it is biocompatible and easily modified, so a gold nano-
rod coating with silica can easily be covalently   conjugated 
with RGD. In this case, RGD-GNRs will   recognize αvβ3 
expression-positive tumor cells, be internalized into cells, 
trapped in endosomes, and degraded within endosome 
compartments. Therefore, the toxic molecules released by 
RGD-GNRs will be harmful to the cancer cells that bind to 
RGD-GNRs. Most normal cells, except for endothelial cells, 
Figure 4 Enhancement of radiation-induced apoptosis by RGD-GNRs. A375 cells were treated with either gold nanorods or RGD-GNRs for one hour prior to irradiation. 
The cells were stained with Annexin V and propidium iodide, and apoptosis was analyzed by flow cytometry after 24 hours of treatment. (A–C) Apoptosis in control cells 
and the cells containing gold nanorods (50 µg/mL for 24 hours) or RGD-GNRs (50 µg/mL for 24 hours) without radiation. (D–F) Apoptosis in radiation alone cells and cells 
containing gold nanorods or RGD-GNRs plus radiation (6 mV x-rays at a dose of 4 Gy). (G) Data from (A–F) were quantified and are presented as the mean ± standard 
deviation (n = 3 experiments). 
Notes: *P , 0.05 compared with control group; **P , 0.05 compared with other treated groups. 
Abbreviations: Ctr, Control Group; GNR, gold nanorod; PI, propidium iodide; RGD-GNRs, arginine-glycine-aspartate-conjugated gold nanorods; RT, radiotherapy. 
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due to the lack of the RGD receptor on the surface of the 
cell membrane, could take up few RGD-GNRs,26 so these 
molecules may be nontoxic to normal cells.
Our results show that RGD-GNRs were readily incorpo-
rated into the cells through integrin αvβ3-receptor-mediated 
endocytosis. RGD-GNRs as a sensitizer could enhance the 
response of radioresistant melanoma cells with a 1.35 dose 
modification factor. The mechanisms whereby RGD-GNRs 
enhanced the response to radiation were associated with 
multiple factors.
In the present study, RGD-GNRs or radiation alone 
resulted in an increase in the percentage of cells in the G2/M 
phase of the cell cycle, while combining these two treatments 
had an additional effect of inducing the cells in the G2/M 
phase. Because tumor cells are more radiosensitive in the 
G2/M phase and less so in the G0/G1 or S phase,27 increased 
radiation-induced cytotoxicity was seen following treatment 
of the cells with a combination of RGD-GNRs and radia-
tion. Likewise, increased cell numbers in the G2/M phase 
could also explain some of the increase in susceptibility 
to   radiation-induced DNA damage reflected by increased 
expression of the DNA repair protein, γH2AX, compared 
with cells treated with radiation alone.28 Our results demon-
strate that disruption of the cell cycle phases by RGD-GNRs 
might determine the relative radiosensitivity of A375 cells.
The radiosensitizing effect by RGD-GNRs might also 
be explained by inhibition of integrin αvβ3 expression. 
A375 melanoma cells that overexpress the integrin αvβ3, show 
elevated levels of the protein following irradiation. RGD-
GNRs, which with the cells were preincubated, inhibited the 
expression of spontaneous and radiation-induced expression 
of integrin αvβ3 and presumably resulted in the sensitization 
of the cells to radiation (Figure 4). There are a number of 
pathways in melanoma cells that contribute to radiation 
resistance, one of which may involve integrin-stimulated 
pathways. It has been reported that the impact on cell survival 
and cell cycle progression in mammalian cells by irradiation 
is strictly controlled by integrin-mediated adhesion to extra-
cellular matrix proteins and the binding of growth factors 
to their cognate receptors.29 Integrin-stimulated pathways 
are similar to and intimately coupled with those pathways 
triggered by growth factors, eg, vascular endothelial growth 
factor receptor 2 (VEGFR2).30 Some studies indicate that 
a direct interplay between αvβ3 and VEGFR-2 occurs at 
the biochemical level.30,31 High VEGFR2 induces a highly 
specific radioprotective effect toward αvβ3 integrin-positive 
endothelial cells in the tumor;32 this results in promoting 
intrinsic radioresistance. On the other hand, radiation upregu-
lates αvβ3 expression and activates Akt, the key antiapoptic 
protein kinase in endothelial cells, thus forming a defense 
mechanism and survival signal against radiation damage.9 
This may account for the acquired radioresistance of tumor 
cells after radiotherapy. Therefore, inhibition of integrin αvβ3 
survival signaling by RGD-GNRs may lead to the reversal 
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of tumor cell resistance to radiotherapy, which is a way to 
enhance the antitumor effects of radiotherapy.
Gold nanorods not only serve as an RGD delivery system 
to improve selective binding to tumor cells and minimize 
damage to surrounding normal tissue, but also have other 
interesting properties, such as increasing the absorption 
of radiation energy and their preferential accumulation in 
cancer cells.28,33 It has long been realized that the effect of 
a defined dosage is increased when a high-Z material is in 
the targeted zone through a photoelectric effect,34 of which 
the   enhancement is proportional to the amount of the high-Z 
material.   Nevertheless, most studies have focused on low-
energy radiation because materials with a high atomic num-
ber, such as gold, preferentially absorb kilovoltage x-rays. 
Megavoltage x-rays, used in the present studies, are more 
commonly used in the clinic, particularly for deep-seated 
tumors. Therefore, the radiosensitizing effect of mV x-rays 
cannot be attributed to high-Z materials alone. Roa et al 
reported35 that one   possibility, in agreement with present 
day data, is an interaction between gold nanorods and the 
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Figure 6 Changes in integrin αvβ3 expression level. (A) A375 cells were treated with either radiation, gold nanorods (50 µg/mL) for one hour, or RGD-GNRs (50 µg/mL) 
for one hour without or with irradiation, and then the cells were stained with anti-integrin αvβ3 antibody LM609 or isotype-matched control antibody DD7 24 hours after 
treatment and αvβ3 expression was measured by flow cytometry. (B) αvβ3 expression was quantified with specific fluorescence intensity; experiments were done in triplicates. 
Columns, mean from three repeated experiments; bars, standard deviation. 
Notes: *P , 0.05 compared with control group; **P , 0.05 compared with radiotherapy alone group. 
Abbreviations: GNR, gold nanorod; RGD-GNRs, arginine-glycine-aspartate-conjugated gold nanorods; RT, radiotherapy.
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cell cycle (Figure 5). Another possible mechanism is that 
gold nanorods, when irradiated in the cell, produce a high 
level of intracellular reactive oxygen species, which leads 
to elevated levels of oxidative stress and is manifested as 
an increased level of apoptosis compared with irradiation 
alone.36 An additional hypothesis proposed as a result of 
work in DNA plasmid models28 is that sensitization occurs 
due to short-range electrons produced by the interaction 
between gold nanorods and mV x-rays. The increased pro-
duction of low-energy electrons close to the DNA causes 
more damage than radiation alone. Our data confirm that 
gold nanorods plus radiation induced more apoptosis and 
mitotic death in A375 cells than radiation alone, and also 
showed that this effect could be significantly enhanced by 
conjugating the gold nanorods to RGD.
In summary, we demonstrated that RGD-GNRs have 
remarkable potential to enhance radiotherapy of melanoma 
cancer cells. RGD-GNRs, in combination with 6 MV 
irradiation, enhance the radiosensitivity of the cells. This 
radiosensitizing effect may be attributable to alterations 
in the capacity of the cell to resist apoptosis caused by 
RGD-GNRs, mainly through downregulation of radiation-
induced αvβ3 and arresting the cell cycle at the G2/M 
phase. Because the success of radiotherapy for patients 
with melanoma largely depends on tumor radiosensitiv-
ity, the combination of RGD-GNRs and radiation needs 
further investigation.
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